Macchi C - Search Results

1

Cardiometabolic risk factors in adults with cystic fibrosis undergoing elexacaftor/tezacaftor/ivacaftor therapy.

Gramegna A, Ruscica M, Leonardi G, Macchi C, Fichtner I, Putti G, Schianca MC, Terranova L, Alicandro G, Blasi F. Gramegna A, et al. Among authors: macchi c. J Cyst Fibros. 2024 Dec 6:S1569-1993(24)01844-7. doi: 10.1016/j.jcf.2024.11.009. Online ahead of print. J Cyst Fibros. 2024. PMID: 39645478 Free article.

2

Lipoprotein(a) and the atherosclerotic burden - Should we wait for clinical trial evidence before taking action?

Fichtner I, Macchi C, Rizzuto AS, Carugo S, Corsini A, Ruscica M. Fichtner I, et al. Among authors: macchi c. Atheroscler Plus. 2024 Sep 26;58:16-23. doi: 10.1016/j.athplu.2024.09.004. eCollection 2024 Dec. Atheroscler Plus. 2024. PMID: 39435317 Free PMC article. Review.

3

Unraveling the Link Between Immunity and Obesity in Adolescents.

Ruscica M, Macchi C, Mauro C. Ruscica M, et al. Among authors: macchi c. J Nutr. 2024 Oct;154(10):2895-2897. doi: 10.1016/j.tjnut.2024.08.019. Epub 2024 Sep 2. J Nutr. 2024. PMID: 39233142 No abstract available.

4

Statin therapy and related risk of new-onset type 2 diabetes mellitus.

Ruscica M, Macchi C, Morlotti B, Sirtori CR, Magni P. Ruscica M, et al. Among authors: macchi c. Eur J Intern Med. 2014 Jun;25(5):401-6. doi: 10.1016/j.ejim.2014.03.003. Epub 2014 Mar 27. Eur J Intern Med. 2014. PMID: 24685426 Review.

5

Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience.

Ruscica M, Macchi C, Iodice S, Tersalvi G, Rota I, Ghidini S, Terranova L, Valenti L, Amati F, Aliberti S, Corsini A, Blasi F, Carugo S, Bollati V, Vicenzi M. Ruscica M, et al. Among authors: macchi c. Eur J Clin Invest. 2021 Sep;51(9):e13629. doi: 10.1111/eci.13629. Epub 2021 Jun 29. Eur J Clin Invest. 2021. PMID: 34184268 Free PMC article.

6

Proteomics and Lipidomics to unveil the contribution of PCSK9 beyond cholesterol lowering: a narrative review.

Gianazza E, Macchi C, Banfi C, Ruscica M. Gianazza E, et al. Among authors: macchi c. Front Cardiovasc Med. 2023 Jun 12;10:1191303. doi: 10.3389/fcvm.2023.1191303. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37378405 Free PMC article. Review.

7

Risk identification and possible countermeasures for muscle adverse effects during statin therapy.

Magni P, Macchi C, Morlotti B, Sirtori CR, Ruscica M. Magni P, et al. Among authors: macchi c. Eur J Intern Med. 2015 Mar;26(2):82-8. doi: 10.1016/j.ejim.2015.01.002. Epub 2015 Jan 29. Eur J Intern Med. 2015. PMID: 25640999 Review.

8

Reduction of Cardio-Metabolic Risk and Body Weight through a Multiphasic Very-Low Calorie Ketogenic Diet Program in Women with Overweight/Obesity: A Study in a Real-World Setting.

Tragni E, Vigna L, Ruscica M, Macchi C, Casula M, Santelia A, Catapano AL, Magni P. Tragni E, et al. Among authors: macchi c. Nutrients. 2021 May 26;13(6):1804. doi: 10.3390/nu13061804. Nutrients. 2021. PMID: 34073344 Free PMC article.

9

HDL in COVID-19 Patients: Evidence from an Italian Cross-Sectional Study.

Papotti B, Macchi C, Favero C, Iodice S, Adorni MP, Zimetti F, Corsini A, Aliberti S, Blasi F, Carugo S, Bollati V, Vicenzi M, Ruscica M. Papotti B, et al. Among authors: macchi c. J Clin Med. 2021 Dec 18;10(24):5955. doi: 10.3390/jcm10245955. J Clin Med. 2021. PMID: 34945250 Free PMC article.

10

Pollution from fine particulate matter and atherosclerosis: A narrative review.

Macchi C, Sirtori CR, Corsini A, Mannuccio Mannucci P, Ruscica M. Macchi C, et al. Environ Int. 2023 May;175:107923. doi: 10.1016/j.envint.2023.107923. Epub 2023 Apr 10. Environ Int. 2023. PMID: 37119653 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

369 results

Search Page

Filters